首页> 美国卫生研究院文献>Microbial Cell Factories >Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization
【2h】

Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization

机译:通过代谢工程和生物工艺优化在酿酒酵母中生产甘露糖基甘油酸酯

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMannosylglycerate (MG) is one of the most widespread compatible solutes among marine microorganisms adapted to hot environments. This ionic solute holds excellent ability to protect proteins against thermal denaturation, hence a large number of biotechnological and clinical applications have been put forward. However, the current prohibitive production costs impose severe constraints towards large-scale applications. All known microbial producers synthesize MG from GDP-mannose and 3-phosphoglycerate via a two-step pathway in which mannosyl-3-phosphoglycerate is the intermediate metabolite. In an early work, this pathway was expressed in Saccharomyces cerevisiae with the goal to confirm gene function (Empadinhas et al. in J Bacteriol 186:4075–4084, ), but the level of MG accumulation was low. Therefore, in view of the potential biotechnological value of this compound, we decided to invest further effort to convert S. cerevisiae into an efficient cell factory for MG production.
机译:背景甘露糖基甘油酸酯(MG​​)是适应高温环境的海洋微生物中最广泛的相容性溶质之一。该离子溶质具有优异的保护蛋白质免于热变性的能力,因此已经提出了许多生物技术和临床应用。但是,当前的高昂生产成本对大规模应用施加了严格的限制。所有已知的微生物生产者都通过两步途径由GDP-甘露糖和3-磷酸甘油酯合成MG,其中3-甘露糖基甘露糖苷是中间体代谢产物。在早期工作中,该途径在酿酒酵母中表达,目的是确认基因功能(Empadinhas等人在《细菌杂志》 186:4075–4084中),但MG的积累水平较低。因此,鉴于该化合物的潜在生物技术价值,我们决定进一步投入努力,将酿酒酵母转化为生产MG的高效细胞工厂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号